VeriMomsr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5) é seguro durante a gravidez?
No harmonised CLP classification, SCCS or CIR reproductive safety assessments, or peer‑reviewed reproductive/toxicity studies identified for the named peptides. These are peptide/protein actives (high molecular weight, proteolytically degradable) with expected minimal dermal systemic bioavailability when used topically, and no evidence of teratogenicity or endocrine activity was found in available sources (ECHA Annex VI; PubMed; CosIng; PubChem).
Related ingredients
Frequently asked questions
- sr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5) é seguro durante a gravidez?
- No harmonised CLP classification, SCCS or CIR reproductive safety assessments, or peer‑reviewed reproductive/toxicity studies identified for the named peptides. These are peptide/protein actives (high molecular weight, proteolytically degradable) with expected minimal dermal systemic bioavailability when used topically, and no evidence of teratogenicity or endocrine activity was found in available sources (ECHA Annex VI; PubMed; CosIng; PubChem).
- sr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5) é seguro durante a amamentação?
- No data indicating reproductive or lactation hazard, no harmonised classifications, and no mechanistic evidence for transfer into breast milk. Topically applied peptides are expected to be degraded and have negligible systemic exposure; no studies suggest transfer to breast milk or effects on nursing infants (sources searched: ECHA Annex VI, PubMed, CosIng, PubChem).
- sr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5) é seguro para a pele do bebê?
- No toxicity or developmental data specific to infants found. Adult hazard/mechanism assessments are absent. Although dermal absorption of intact peptides is expected to be very low, infant (0–3 yr) skin has higher surface-area-to-weight and immature barrier function, so exposure score is increased by +1 to reflect potentially higher but still likely low absorption; no evidence of infant-specific adverse effects was identified (sources: PubMed, CosIng, ECHA Annex VI, PubChem).
- Como o VeriMom pontua sr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5)?
- O VeriMom pontua sr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5) em 100/100 (sem riscos conhecidos) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.
- Quais são as alternativas seguras a sr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5) na gravidez?
- Veja nossa lista curada de alternativas seguras a sr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5) com base em função semelhante e classificação sem riscos conhecidos.
Verifique qualquer rótulo em 2 segundos
Baixe o VeriMom grátis — escaneie qualquer produto e veja a pontuação de segurança na gravidez instantaneamente.
Aviso Médico
Estas informações são apenas para fins educacionais e não constituem aconselhamento médico. As pontuações de segurança são baseadas em dados publicamente disponíveis e podem não refletir todos os riscos. Sempre consulte seu profissional de saúde antes de usar qualquer produto durante a gravidez ou amamentação.